Richard S.E. Keefe | Scholars@Duke

Richard S.E. Keefe
Professor in Psychiatry and Behavioral Sciences

Schizophrenia, psychosis, cognition, pharmacologic treatment of cognitive impairment, sport psychology, functional imaging (PET, fMRI), frontal cortex, motor functions.

Current Appointments and Affiliations

Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2007
Professor in the Department of Psychology & Neuroscience, Psychology and Neuroscience, Trinity College of Arts & Sciences 2011
Faculty Network Member of the Duke Institute for Brain Sciences, Duke Institute for Brain Sciences, University Institutes and Centers 2008
Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2016

Contact Information

4080 Hosp South, Durham, NC 27710
Box 3270 Med Ctr, Durham, NC 27710
richard.keefe@duke.edu (919) 684-4306

Background
Education, Training, and Certifications
- Ph.D., New York University 1990
Recognition
In the News
- APR 24, 2014 The News & Observer
  
  Richard Keefe: Bruce Springsteen offers chance to recall impulsiveness of teen brains
Expertise
Global Scholarship
- Expertise
  - Singapore (Country)
- Research
  - Singapore (Country)
Research
Selected Grants
- Auditory Perception and Emotion Recognition in Young People at Risk for Psychosis awarded by National Institutes of Health 2016 - 2018
- FAST- MAS Phase 2A awarded by National Institutes of Health 2013 - 2017
- Specific Auditory Perception Impairment and Emotion Recognition in Schizophrenia awarded by National Institutes of Health 2014 - 2017
- FAST- MAS Administrative Task Year 3 awarded by National Institutes of Health 2014 - 2015
- IPA - Richard Keefe awarded by Durham Veterans Affairs Medical Center 2013 - 2014
- IPA - Richard Keefe awarded by Veterans Administration Medical Center 2012 - 2013
- IPA - Richard Keefe awarded by Veterans Administration Medical Center 2010 - 2011
- Neural Circuitry And Cognitive Function In Schizophrenia awarded by National Institutes of Health 1995 - 2001
- Neural Circuitry & Cognitive Function In Schizophrenia awarded by National Institutes of Health 1995 - 1999
- Neural Circuitry & Function In Schizophrenia awarded by National Institutes of Health 1995 - 1999
- Neural Corcuitry And Cognitive Function In Schizophrenia awarded by National Institutes of Health 1995 - 1999
Publications and Artistic Works
Selected Publications
- Book Sections
  - Vance, M, Pappadopulos, E, Keefe, R, and Kalali, A. "Conceptual issues in cultural adaptation and the role of culture in assessment of health-related quality of life in schizophrenia." In Beyond Assessment of Quality of Life in Schizophrenia, 53-62. January 1, 2016. Full Text
- Conference Papers
  - Eum, S, Hill, SK, Rubin, LH, Carnahan, RM, Reilly, JL, Ivleva, EI, Keedy, SK, Tamminga, CA, Pearlson, GD, Clementz, BA, Gershon, ES, Keshavan, MS, Keefe, RSE, Sweeney, JA, and Bishop, JR. "Cognitive burden of anticholinergic medications in psychotic disorders." April 5, 2017. Full Text
  - Graham, KA, Keefe, RS, Lieberman, JA, Calikoglu, AS, Lansing, KM, and Perkins, DO. "Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia." October 2015. Full Text
- Journal Articles
  - Mazhari, S, Ghafaree-Nejad, AR, Soleymani-Zade, S, and Keefe, RSE. "Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia (Accepted)." Asian Journal of Psychiatry 27 (June 2017): 12-15. Full Text
  - Hochberger, WC, Combs, T, Reilly, JL, Bishop, JR, Keefe, RSE, Clementz, BA, Keshavan, MS, Pearlson, GD, Tamminga, CA, Hill, SK, and Sweeney, JA. "Deviation from expected cognitive ability across psychotic disorders." Schizophrenia research (May 22, 2017). Full Text
  - Lam, M, Wang, M, Huang, W, Eng, GK, Rapisarda, A, Kraus, M, Kang, S, Keefe, RSE, and Lee, J. "Establishing the Brief Assessment of Cognition - Short form." Journal of psychiatric research 93 (May 17, 2017): 1-11. Full Text
  - Atkins, AS, Tseng, T, Vaughan, A, Twamley, EW, Harvey, P, Patterson, T, Narasimhan, M, and Keefe, RSE. "Validation of the tablet-administered Brief Assessment of Cognition (BAC App)." Schizophrenia research 181 (March 2017): 100-106. Full Text
  - Addington, J, Liu, L, Perkins, DO, Carrion, RE, Keefe, RSE, and Woods, SW. "The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms." Schizophrenia bulletin 43, no. 1 (January 2017): 57-63. Full Text
  - Kraus, M, Rapisarda, A, Lam, M, Thong, JYJ, Lee, J, Subramaniam, M, Collinson, SL, Chong, SA, and Keefe, RSE. "Disrupted latent inhibition in individuals at ultra high-risk for developing psychosis." Schizophrenia Research: Cognition 6 (December 2016): 1-8. Full Text
  - Mahableshwarkar, AR, Zajecka, J, Jacobson, W, Chen, Y, and Keefe, RS. "A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 41, no. 12 (November 2016): 2961-. Full Text
  - Kantrowitz, JT, Medalia, A, Keefe, RSE, Harvey, PD, Bruder, G, Barch, DM, Choo, T, Lee, S, and Lieberman, JA. "Dr Kantrowitz and Colleagues Reply." The Journal of clinical psychiatry 77, no. 10 (October 2016): e1353-. Full Text
  - Wang, C, Ji, F, Hong, Z, Poh, JS, Krishnan, R, Lee, J, Rekhi, G, Keefe, RSE, Adcock, RA, Wood, SJ, Fornito, A, Pasternak, O, Chee, MWL, and Zhou, J. "Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study." Psychological medicine 46, no. 13 (October 2016): 2771-2783. Full Text
  - Keefe, RSE, Davis, VG, Atkins, AS, Vaughan, A, Patterson, T, Narasimhan, M, and Harvey, PD. "Validation of a Computerized test of Functional Capacity." Schizophrenia research 175, no. 1-3 (August 2016): 90-96. Full Text
  - Cruz, BF, Resende, CBD, Carvalhaes, CF, Cardoso, CS, Teixeira, AL, Keefe, RS, Rocha, FL, and Salgado, JV. "Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms." Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 38, no. 3 (July 2016): 216-221. Full Text
  - Lim, J, Lee, S-A, Lam, M, Rapisarda, A, Kraus, M, Keefe, RSE, and Lee, J. "The relationship between negative symptom subdomains and cognition." Psychological medicine 46, no. 10 (July 2016): 2169-2177. Full Text
  - Kantrowitz, JT, Sharif, Z, Medalia, A, Keefe, RSE, Harvey, P, Bruder, G, Barch, DM, Choo, T, Lee, S, and Lieberman, JA. "A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder." The Journal of clinical psychiatry 77, no. 6 (June 2016): 799-806. Full Text
  - Keefe, RSE, and Reichenberg, A. "Predicting Schizophrenia." JAMA psychiatry 73, no. 5 (May 2016): 441-442. Full Text
  - Keefe, RSE. "Treating cognitive impairment in depression: an unmet need." The lancet. Psychiatry 3, no. 5 (May 2016): 392-393. Full Text
  - Walling, D, Marder, SR, Kane, J, Fleischhacker, WW, Keefe, RSE, Hosford, DA, Dvergsten, C, Segreti, AC, Beaver, JS, Toler, SM, Jett, JE, and Dunbar, GC. "Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia." Schizophrenia bulletin 42, no. 2 (March 2016): 335-343. Full Text
  - Hochberger, WC, Hill, SK, Nelson, CLM, Reilly, JL, Keefe, RSE, Pearlson, GD, Keshavan, MS, Tamminga, CA, Clementz, BA, and Sweeney, JA. "Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives." Schizophrenia research 170, no. 1 (January 2016): 156-161. Full Text
  - Keefe, RSE, Haig, GM, Marder, SR, Harvey, PD, Dunayevich, E, Medalia, A, Davidson, M, Lombardo, I, Bowie, CR, Buchanan, RW, Bugarski-Kirola, D, Carpenter, WT, Csernansky, JT, Dago, PL, Durand, DM, Frese, FJ, Goff, DC, Gold, JM, Hooker, CI, Kopelowicz, A, Loebel, A, McGurk, SR, Opler, LA, Pinkham, AE, and Stern, RG. "Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia." Schizophrenia bulletin 42, no. 1 (January 2016): 19-33. Full Text
  - Keefe, RSE, Meltzer, HA, Dgetluck, N, Gawryl, M, Koenig, G, Moebius, HJ, Lombardo, I, and Hilt, DC. "Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 40, no. 13 (December 2015): 3053-3060. Full Text
  - Keefe, RSE, and Harvey, PD. "Understanding symbol coding in schizophrenia." Biological psychiatry 78, no. 11 (December 2015): 744-746. Full Text
  - Klauser, P, Zhou, J, Lim, JKW, Poh, JS, Zheng, H, Tng, HY, Krishnan, R, Lee, J, Keefe, RSE, Adcock, RA, Wood, SJ, Fornito, A, and Chee, MWL. "Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study." Schizophrenia bulletin 41, no. 6 (November 2015): 1285-1293. Full Text
  - Iwata, Y, Nakajima, S, Suzuki, T, Keefe, RSE, Plitman, E, Chung, JK, Caravaggio, F, Mimura, M, Graff-Guerrero, A, and Uchida, H. "Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials." Molecular psychiatry 20, no. 10 (October 2015): 1151-1160. (Review) Full Text
  - Kelly, DL, Sullivan, KM, McEvoy, JP, McMahon, RP, Wehring, HJ, Gold, JM, Liu, F, Warfel, D, Vyas, G, Richardson, CM, Fischer, BA, Keller, WR, Koola, MM, Feldman, SM, Russ, JC, Keefe, RSE, Osing, J, Hubzin, L, August, S, Walker, TM, and Buchanan, RW. "Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms." Journal of clinical psychopharmacology 35, no. 4 (August 2015): 374-381. Full Text
  - Kristian Hill, S, Buchholz, A, Amsbaugh, H, Reilly, JL, Rubin, LH, Gold, JM, Keefe, RSE, Pearlson, GD, Keshavan, MS, Tamminga, CA, and Sweeney, JA. "Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment." Schizophrenia research 166, no. 1-3 (August 2015): 310-315. Full Text
  - Hill, SK, Reilly, JL, Ragozzino, ME, Rubin, LH, Bishop, JR, Gur, RC, Gershon, ES, Tamminga, CA, Pearlson, GD, Keshavan, MS, Keefe, RSE, and Sweeney, JA. "Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study." Schizophrenia bulletin 41, no. 4 (July 2015): 940-950. Full Text
  - Mahableshwarkar, AR, Zajecka, J, Jacobson, W, Chen, Y, and Keefe, RSE. "A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 40, no. 8 (July 2015): 2025-2037. Full Text
  - Jarskog, LF, Lowy, MT, Grove, RA, Keefe, RSE, Horrigan, JP, Ball, MP, Breier, A, Buchanan, RW, Carter, CS, Csernansky, JG, Goff, DC, Green, MF, Kantrowitz, JT, Keshavan, MS, Laurelle, M, Lieberman, JA, Marder, SR, Maruff, P, McMahon, RP, Seidman, LJ, and Peykamian, MA. "A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy." Schizophrenia research 164, no. 1-3 (May 2015): 136-142. Full Text
  - Lim, J, Rekhi, G, Rapisarda, A, Lam, M, Kraus, M, Keefe, RSE, and Lee, J. "Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS)." Schizophrenia research 164, no. 1-3 (May 2015): 8-14. Full Text
  - Araújo, GE, Resende, CBD, Cardoso, ACA, Teixeira, AL, Keefe, RSE, and Salgado, JV. "Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia)." Clinics (Sao Paulo, Brazil) 70, no. 4 (April 2015): 278-282. Full Text
  - Bauer, IE, Ouyang, A, Mwangi, B, Sanches, M, Zunta-Soares, GB, Keefe, RSE, Huang, H, and Soares, JC. "Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study." Journal of psychiatric research 62 (March 2015): 115-122. Full Text
  - Keefe, RSE, Davis, VG, Spagnola, NB, Hilt, D, Dgetluck, N, Ruse, S, Patterson, TD, Narasimhan, M, and Harvey, PD. "Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 25, no. 2 (February 2015): 176-184. Full Text
  - Bauer, IE, Keefe, RSE, Sanches, M, Suchting, R, Green, CE, and Soares, JC. "Evaluation of cognitive function in bipolar disorder using the Brief Assessment of Cognition in Affective Disorders (BAC-A)." Journal of psychiatric research 60 (January 2015): 81-86. Full Text
  - Graham, KA, Keefe, RS, Lieberman, JA, Calikoglu, AS, Lansing, KM, and Perkins, DO. "Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia." Early Intervention in Psychiatry 9, no. 5 (2015): 397-405. Full Text
  - Harvey, PD, and Keefe, RSE. "Methods for delivering and evaluating the efficacy of cognitive enhancement." Handbook of experimental pharmacology 228 (January 2015): 5-25. Full Text
  - Healey, KM, Combs, DR, Gibson, CM, Keefe, RSE, Roberts, DL, and Penn, DL. "Observable Social Cognition--A Rating Scale: an interview-based assessment for schizophrenia." Cognitive neuropsychiatry 20, no. 3 (January 2015): 198-221. Full Text
  - Jarskog, LF, Lowy, MT, Grove, RA, Keefe, RSE, Horrigan, JP, Ball, MP, Breier, A, Buchanan, RW, Carter, CS, Csernansky, JG, Goff, DC, Green, MF, Kantrowitz, JT, Keshavan, MS, Laurelle, M, Lieberman, JA, Marder, SR, Maruff, P, McMahon, RP, Seidman, LJ, and Peykamian, MA. "A Phase II study of a histamine H<inf>3</inf> receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy." Schizophrenia Research 164, no. 1-3 (January 1, 2015): 136-142. Full Text
  - Keefe, RSE, Davis, VG, Spagnola, NB, Hilt, D, Dgetluck, N, Ruse, S, Patterson, TD, Narasimhan, M, and Harvey, PD. "Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale." European Neuropsychopharmacology 25, no. 2 (2015): 176-184. Full Text
  - Lui, S, Yao, L, Xiao, Y, Keedy, SK, Reilly, JL, Keefe, RS, Tamminga, CA, Keshavan, MS, Pearlson, GD, Gong, Q, and Sweeney, JA. "Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives." Psychological medicine 45, no. 1 (January 2015): 97-108. Full Text
  - McCleery, A, Green, MF, Hellemann, GS, Baade, LE, Gold, JM, Keefe, RSE, Kern, RS, Mesholam-Gately, RI, Seidman, LJ, Subotnik, KL, Ventura, J, and Nuechterlein, KH. "Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB)." Psychological medicine 45, no. 12 (January 2015): 2657-2666. Full Text
  - Yasuhiro Kaneda, MD, and Keefe, RSE. "An abbreviated version of the brief assessment of cognition in schizophrenia (BACS)." The European Journal of Psychiatry 29, no. 2 (2015): 131-134. Full Text
  - Lam, M, Collinson, SL, Eng, GK, Rapisarda, A, Kraus, M, Lee, J, Chong, SA, and Keefe, RSE. "Refining the latent structure of neuropsychological performance in schizophrenia." Psychological medicine 44, no. 16 (December 2014): 3557-3570. Full Text
  - Ethridge, LE, Soilleux, M, Nakonezny, PA, Reilly, JL, Hill, SK, Keefe, RSE, Gershon, ES, Pearlson, GD, Tamminga, CA, Keshavan, MS, and Sweeney, JA. "Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit." Schizophrenia research 159, no. 2-3 (November 2014): 491-498. Full Text
  - Gray, BE, McMahon, RP, Green, MF, Seidman, LJ, Mesholam-Gately, RI, Kern, RS, Nuechterlein, KH, Keefe, RS, and Gold, JM. "Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery." Schizophrenia research 159, no. 1 (October 2014): 182-187. Full Text
  - Hufford, MR, Davis, VG, Hilt, D, Dgetluck, N, Geffen, Y, Loebel, A, Haig, G, Santarelli, L, and Keefe, RSE. "Circadian rhythms in cognitive functioning among patients with schizophrenia: impact on signal detection in clinical trials of potential pro-cognitive therapies." Schizophrenia research 159, no. 1 (October 2014): 205-210. Full Text
  - Keefe, RSE, Fox, KH, Davis, VG, Kennel, C, Walker, TM, Burdick, KE, and Harvey, PD. "The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls." Journal of affective disorders 166 (September 2014): 86-92. Full Text
  - Keefe, RSE. "Cognition and motivation as treatment targets in schizophrenia." JAMA psychiatry 71, no. 9 (September 2014): 987-988. Full Text
  - Marx, CE, Lee, J, Subramaniam, M, Rapisarda, A, Bautista, DCT, Chan, E, Kilts, JD, Buchanan, RW, Wai, EP, Verma, S, Sim, K, Hariram, J, Jacob, R, Keefe, RSE, and Chong, SA. "Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia." Psychopharmacology 231, no. 17 (September 2014): 3647-3662. Full Text
  - Marx, CE, Lee, J, Subramaniam, M, Rapisarda, A, Bautista, DCT, Chan, E, Kilts, JD, Buchanan, RW, Wai, EP, Verma, S, Sim, K, Hariram, J, Jacob, R, Keefe, RSE, and Chong, SA. "Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia." Psychopharmacology 231, no. 17 (September 1, 2014): 3647-3662. Full Text
  - Reilly, JL, Frankovich, K, Hill, S, Gershon, ES, Keefe, RSE, Keshavan, MS, Pearlson, GD, Tamminga, CA, and Sweeney, JA. "Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories." Schizophrenia bulletin 40, no. 5 (September 2014): 1011-1021. Full Text
  - Stout, JC, Queller, S, Baker, KN, Cowlishaw, S, Sampaio, C, Fitzer-Attas, C, and Borowsky, B. "HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3." Movement disorders : official journal of the Movement Disorder Society 29, no. 10 (September 2014): 1281-1288. Full Text
  - Keefe, RSE, McClintock, SM, Roth, RM, Doraiswamy, PM, Tiger, S, and Madhoo, M. "Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review." The Journal of clinical psychiatry 75, no. 8 (August 2014): 864-876. (Review) Full Text
  - Yong, E, Barbato, M, Penn, DL, Keefe, RSE, Woods, SW, Perkins, DO, and Addington, J. "Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis." Psychiatry research 218, no. 1-2 (August 2014): 39-43. Full Text
  - Dandash, O, Fornito, A, Lee, J, Keefe, RSE, Chee, MWL, Adcock, RA, Pantelis, C, Wood, SJ, and Harrison, BJ. "Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis." Schizophrenia bulletin 40, no. 4 (July 2014): 904-913. Full Text
  - Rapisarda, A, Kraus, M, Tan, YW, Lam, M, Eng, GK, Lee, J, Subramaniam, M, Collinson, SL, Chong, SA, and Keefe, RSE. "The continuous performance test, identical pairs: norms, reliability and performance in healthy controls and patients with schizophrenia in Singapore." Schizophrenia research 156, no. 2-3 (July 2014): 233-240. Full Text
  - Rapisarda, A, Kraus, M, Tan, YW, Lam, M, Eng, GK, Lee, J, Subramaniam, M, Collinson, SL, Chong, SA, and Keefe, RSE. "The Continuous Performance Test, Identical Pairs: norms, reliability and performance in healthy controls and patients with schizophrenia in Singapore." Schizophrenia Research 156, no. 2-3 (July 2014): 233-240. Full Text
  - Umbricht, D, Keefe, RSE, Murray, S, Lowe, DA, Porter, R, Garibaldi, G, and Santarelli, L. "A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 39, no. 7 (June 2014): 1568-1577. Full Text
  - Madhoo, M, Keefe, RSE, Roth, RM, Sambunaris, A, Wu, J, Trivedi, MH, Anderson, CS, and Lasser, R. "Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 39, no. 6 (May 2014): 1388-1398. Full Text
  - Ruse, SA, Davis, VG, Atkins, AS, Krishnan, KRR, Fox, KH, Harvey, PD, and Keefe, RSE. "Development of a virtual reality assessment of everyday living skills." Journal of visualized experiments : JoVE , no. 86 (April 23, 2014). Full Text
  - Ruse, SA, Harvey, PD, Davis, VG, Atkins, AS, Fox, KH, and Keefe, RSE. "Virtual Reality Functional Capacity Assessment In Schizophrenia: Preliminary Data Regarding Feasibility and Correlations with Cognitive and Functional Capacity Performance." Schizophrenia research. Cognition 1, no. 1 (March 2014): e21-e26. Full Text
  - Gray, BE, McMahon, RP, Green, MF, Seidman, LJ, Mesholam-Gately, RI, Kern, RS, Nuechterlein, KH, Keefe, RS, and Gold, JM. "Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery." Schizophrenia Research 159, no. 1 (2014): 182-187. Full Text
  - Hufford, MR, Davis, VG, Hilt, D, Dgetluck, N, Geffen, Y, Loebel, A, Haig, G, Santarelli, L, and Keefe, RSE. "Circadian rhythms in cognitive functioning among patients with schizophrenia: Impact on signal detection in clinical trials of potential pro-cognitive therapies." Schizophrenia Research 159, no. 1 (2014): 205-210. Full Text
  - Keefe, RSE. "The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness." The Journal of clinical psychiatry 75 Suppl 2 (January 2014): 8-13. (Review) Full Text
  - Lam, M, Collinson, SL, Eng, GK, Rapisarda, A, Kraus, M, Lee, J, Chong, SA, and Keefe, RSE. "Refining the latent structure of neuropsychological performance in schizophrenia." Psychological Medicine 44, no. 16 (January 1, 2014): 3557-3570. Full Text
  - Madhoo, M, Keefe, RSE, Roth, RM, Sambunaris, A, Wu, J, Trivedi, MH, Anderson, CS, and Lasser, R. "Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder." Neuropsychopharmacology 39, no. 6 (2014): 1388-1398. Full Text
  - Mazhari, S, Parvaresh, N, Shahrbabaki, ME, Sadeghi, MM, Nakhaee, N, and Keefe, RSE. "Validation of the Persian version of the brief assessment of cognition in schizophrenia in patients with schizophrenia and healthy controls." Psychiatry and clinical neurosciences 68, no. 2 (2014): 160-166. Full Text
  - Meier, MH, Caspi, A, Reichenberg, A, Keefe, RSE, Fisher, HL, Harrington, H, Houts, R, Poulton, R, and Moffitt, TE. "Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study." The American journal of psychiatry 171, no. 1 (January 2014): 91-101. Full Text
  - Ruse, SA, Davis, VG, Atkins, AS, Krishnan, KRR, Fox, KH, Harvey, PD, and Keefe, RSE. "Development of a virtual reality assessment of everyday living skills." Journal of visualized experiments : JoVE , no. 86 (2014). Full Text
  - Umbricht, D, Keefe, RSE, Murray, S, Lowe, DA, Porter, R, Garibaldi, G, and Santarelli, L. "A randomized, placebo-controlled study investigating the nicotinic 7 agonist, RG3487, for cognitive deficits in schizophrenia." Neuropsychopharmacology 39, no. 7 (2014): 1568-1577. Full Text
  - Yong, E, Barbato, M, Penn, DL, Keefe, RSE, Woods, SW, Perkins, DO, and Addington, J. "Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis." Psychiatry Research 218, no. 1-2 (2014): 39-43. Full Text
  - Abdul Rashid, NA, Lim, J, Lam, M, Chong, SA, Keefe, RSE, and Lee, J. "Unraveling the relationship between obesity, schizophrenia and cognition." Schizophrenia Research 151, no. 1-3 (December 1, 2013): 107-112. Full Text
  - Eng, GK, Lam, M, Bong, YL, Subramaniam, M, Bautista, D, Rapisarda, A, Kraus, M, Lee, J, Collinson, SL, Chong, SA, and Keefe, RSE. "Brief Assessment of Cognition in Schizophrenia: Normative Data in an English-Speaking Ethnic Chinese Sample." ARCHIVES OF CLINICAL NEUROPSYCHOLOGY 28, no. 8 (December 2013): 845-858. Full Text Link to Item
  - Lee, J, Rekhi, G, Mitter, N, Bong, YL, Kraus, MS, Lam, M, Rapisarda, A, Lee, T-S, Subramaniam, M, Chong, SA, and Keefe, RSE. "The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR perspective." Schizophr Res 151, no. 1-3 (December 2013): 279-283. Full Text Link to Item
  - Lee, J, Rekhi, G, Mitter, N, Bong, YL, Kraus, MS, Lam, M, Rapisarda, A, Lee, TS, Subramaniam, M, Chong, SA, and Keefe, RSE. "The Longitudinal Youth at Risk Study (LYRIKS) - An Asian UHR perspective." Schizophrenia Research 151, no. 1-3 (December 1, 2013): 279-283. Full Text
  - Meier, MH, Shalev, I, Moffitt, TE, Kapur, S, Keefe, RSE, Wong, TY, Belsky, DW, Harrington, H, Hogan, S, Houts, R, Caspi, A, and Poulton, R. "Microvascular abnormality in schizophrenia as shown by retinal imaging." Am J Psychiatry 170, no. 12 (December 2013): 1451-1459. Full Text Link to Item
  - Hill, SK, Reilly, JL, Keefe, RSE, Gold, JM, Bishop, JR, Gershon, ES, Tamminga, CA, Pearlson, GD, Keshavan, MS, and Sweeney, JA. "Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study." AMERICAN JOURNAL OF PSYCHIATRY 170, no. 11 (November 2013): 1275-1284. Full Text Link to Item
  - Yaakub, SN, Dorairaj, K, Poh, JS, Asplund, CL, Krishnan, R, Lee, J, Keefe, RSE, Adcock, RA, Wood, SJ, and Chee, MWL. "Preserved Working Memory and Altered Brain Activation in Persons at Risk for Psychosis." AMERICAN JOURNAL OF PSYCHIATRY 170, no. 11 (November 2013): 1297-1307. Full Text Link to Item
  - Kahn, RS, and Keefe, RSE. "Schizophrenia Is a Cognitive Illness Time for a Change in Focus." JAMA PSYCHIATRY 70, no. 10 (October 2013): 1107-1112. Full Text Link to Item
  - Keefe, RSE, Kraemer, HC, Epstein, RS, Frank, E, Haynes, G, Laughren, TP, McNulty, J, Reed, SD, Sanchez, J, and Leon, AC. "Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials." Innovations in Clinical Neuroscience 10, no. 5-6 (May 1, 2013).
  - Keefe, RSE, Buchanan, RW, Marder, SR, Schooler, NR, Dugar, A, Zivkov, M, and Stewart, M. "Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?." SCHIZOPHRENIA BULLETIN 39, no. 2 (March 2013): 417-435. Full Text Link to Item
  - Lam, M, Eng, GK, Rapisarda, A, Subramaniam, M, Kraus, M, Keefe, RSE, and Collinson, SL. "Formulation of the Age-Education Index: Measuring Age and Education Effects in Neuropsychological Performance." PSYCHOLOGICAL ASSESSMENT 25, no. 1 (March 2013): 61-70. Full Text Link to Item
  - Barbato, M, Colijn, MA, Keefe, RSE, Perkins, DO, Woods, SW, Hawkins, KA, Christensen, BK, and Addington, J. "The course of cognitive functioning over six months in individuals at clinical high risk for psychosis." Psychiatry research 206, no. 2-3 (2013): 195-199. Full Text
  - Barbato, M, Liu, L, Penn, DL, Keefe, RSE, Perkins, DO, Woods, SW, and Addington, J. "Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis." Schizophrenia Research 150, no. 2-3 (2013): 542-546. Full Text
  - Barbato, M, Liu, L, Penn, DL, Keefe, RSE, Perkins, DO, Woods, SW, and Addington, J. "Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis." Schizophrenia Research (2013). Full Text
  - Cruz, BF, Resende, CBD, Abreu, MN, Rocha, FL, Teixeira, AL, Keefe, RSE, and Salgado, JV. "How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS." Cognitive Neuropsychiatry 18, no. 3 (2013): 243-251. Full Text
  - Jarskog, LF, Dong, Z, Kangarlu, A, Colibazzi, T, Girgis, RR, Kegeles, LS, Barch, DM, Buchanan, RW, Csernansky, JG, Goff, DC, Harms, MP, Javitt, DC, Keefe, RS, McEvoy, JP, McMahon, RP, Marder, SR, Peterson, BS, and Lieberman, JA. "Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia." Neuropsychopharmacology 38, no. 7 (2013): 1245-1252. Full Text
  - Jarskog, LF, Dong, Z, Kangarlu, A, Colibazzi, T, Girgis, RR, Kegeles, LS, Barch, DM, Buchanan, RW, Csernansky, JG, Goff, DC, and al, E. "Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia." Neuropsychopharmacology (2013). Full Text
  - Kim, JL, Rele, S, Marks, DM, Masand, PS, Yerramsetty, P, Millet, RA, Keefe, RS, and Patkar, AA. "Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial." The primary care companion for CNS disorders 15, no. 6 (January 2013). Full Text
  - Lee, T-S, Goh, SJA, Quek, SY, Phillips, R, Guan, C, Cheung, YB, Feng, L, Teng, SSW, Wang, CC, Chin, ZY, Zhang, H, Ng, TP, Lee, J, Keefe, R, and Krishnan, KRR. "A brain-computer interface based cognitive training system for healthy elderly: a randomized control pilot study for usability and preliminary efficacy." PloS one 8, no. 11 (January 2013): e79419-. Full Text
  - Marder, SR, Alphs, L, Anghelescu, I-G, Arango, C, Barnes, TRE, Caers, I, Daniel, DG, Duneyevich, E, Fleischhacker, WW, Garibaldi, G, and al, E. "Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia." Schizophrenia Research (2013). Full Text
  - Marder, SR, Alphs, L, Anghelescu, IG, Arango, C, Barnes, TRE, Caers, I, Daniel, DG, Dunayevich, E, Fleischhacker, WW, Garibaldi, G, and al, E. "Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia." Schizophrenia Research 150, no. 2-3 (2013): 328-333. Full Text
  - Mazhari, S, Parvaresh, N, Shahrbabaki, ME, Sadeghi, MM, Nakhaee, N, and Keefe, RSE. "Validation of the Persian version of the Brief Assessment of Cognition in Schizophrenia in patients with schizophrenia and healthy controls." Psychiatry and Clinical Neurosciences (2013). Full Text
  - Nutt, D, Wied, CCG-D, Arango, C, Keefe, RSE, Penadés, R, Murphy, DG, Robbins, TW, and Sahakian, BJ. "Cognition in schizophrenia: Summary Nice Consultation Meeting 2012." European Neuropsychopharmacology (2013). Full Text
  - Nutt, D, Wied, CCGD, Arango, C, Keefe, RSE, Penadés, R, Murphy, DG, Robbins, TW, and Sahakian, BJ. "Cognition in schizophrenia: Summary nice consultation meeting 2012." European Neuropsychopharmacology 23, no. 8 (2013): 769-778. Full Text
  - Rapisarda, A, Lim, TF, Lim, M, Collinson, SL, Kraus, MS, and Keefe, RSE. "Applicability of the MATRICS Consensus Cognitive Battery in Singapore." Clinical Neuropsychologist (2013). Full Text
  - Rapisarda, A, Lim, TF, Lim, M, Collinson, SL, Kraus, MS, and Keefe, RSE. "Applicability of the MATRICS consensus cognitive battery in Singapore." Clinical Neuropsychologist 27, no. 3 (2013): 455-469. Full Text
  - Rashid, NAA, Lim, J, Lam, M, Chong, S-A, Keefe, RSE, and Lee, J. "Unraveling the relationship between obesity, schizophrenia and cognition." Schizophrenia Research (2013). Full Text
  - Sakurai, H, Bies, RR, Stroup, ST, Keefe, RSE, Rajji, TK, Suzuki, T, Mamo, DC, Pollock, BG, Watanabe, K, Mimura, M, and Uchida, H. "Dopamine D₂ receptor occupancy and cognition in schizophrenia: Analysis of the CATIE data." Schizophrenia Bulletin 39, no. 3 (2013): 564-574. Full Text
  - Ventura, J, Reise, SP, Keefe, RSE, Hurford, IM, Wood, RC, and Bilder, RM. "The Cognitive Assessment Interview (CAI): Reliability and validity of a brief interview-based measure of cognition." Schizophrenia Bulletin 39, no. 3 (2013): 583-591. Full Text
  - Vita, A, Deste, G, Barlati, S, Peri, LD, Giambra, A, Poli, R, Keefe, RSE, and Sacchetti, E. "Interview-based assessment of cognition in schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care." Schizophrenia Research (2013). Full Text
  - Vita, A, Deste, G, Barlati, S, Peri, LD, Giambra, A, Poli, R, Keefe, RSE, and Sacchetti, E. "Interview-based assessment of cognition in schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care." Schizophrenia Research 146, no. 1-3 (2013): 217-223. Full Text
  - Meier, MH, Caspi, A, Ambler, A, Harrington, H, Houts, R, Keefe, RSE, McDonald, K, Ward, A, Poulton, R, and Moffitt, TE. "Persistent cannabis users show neuropsychological decline from childhood to midlife." Proc Natl Acad Sci U S A 109, no. 40 (October 2, 2012): E2657-E2664. Full Text Link to Item
  - Barbato, M, Colijn, MA, Keefe, RSE, Perkins, DO, Woods, SW, Hawkins, KA, Christensen, BK, and Addington, J. "The course of cognitive functioning over six months in individuals at clinical high risk for psychosis." Psychiatry Research (2012). Full Text
  - Cruz, BF, Resende, CBD, Abreu, MN, Fá, FLR, Teixeira, AL, Keefe, RSE, and SalgadoJoã, JV. "How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS." Cognitive Neuropsychiatry (2012). Full Text
  - Geffen, Y, Keefe, R, Rabinowitz, J, Anand, R, and Davidson, M. "BL-1020, a new γ-aminobutyric acid-enhanced antipsychotic: Results of 6-week, randomized, double-blind, controlled, efficacy and safety study." Journal of Clinical Psychiatry 73, no. 9 (2012): e1168-e1174. Full Text
  - Harvey, PD, and Keefe, RS. "Technology, society, and mental illness: Challenges and opportunities for assessment and treatment." Innovations in Clinical Neuroscience 9, no. 11-12 (2012): 47-50.
  - Javitt, DC, Buchanan, RW, Keefe, RSE, Kern, R, McMahon, RP, Green, MF, Lieberman, J, Goff, DC, Csernansky, JG, McEvoy, JP, Jarskog, F, Seidman, LJ, Gold, JM, Kimhy, D, Nolan, KS, Barch, DS, Ball, MP, Robinson, J, and Marder, SR. "Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia." Schizophrenia Research 136, no. 1-3 (2012): 25-31. Full Text
  - Kahn, PV, Walker, TM, Williams, TS, Cornblatt, BA, Mohs, RC, and Keefe, RSE. "Standardizing the use of the Continuous Performance Test in schizophrenia research: A validation study." Schizophrenia Research 142, no. 1-3 (2012): 153-158. Full Text
  - Keefe, RSE, Vinogradov, S, Medalia, A, Buckley, PF, Caroff, SN, D'Souza, DC, Harvey, PD, Graham, KA, Hamer, RM, Marder, SM, Miller, DD, Olson, SJ, Patel, JK, Velligan, D, Walker, TM, Haim, AJ, and Stroup, TS. "Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial." Journal of Clinical Psychiatry 73, no. 7 (2012): 1016-1022. Full Text
  - Keefe, RSE, and Harvey, PD. "Cognitive impairment in schizophrenia." Handbook of Experimental Pharmacology 213 (2012): 11-37. Full Text
  - Keefe, RSE, and Kraus, MS. "Clues to the cognitive and perceptual origins of social isolation and psychosis in schizophrenia." American Journal of Psychiatry 169, no. 4 (2012): 354-357. Full Text
  - Krishnan, RR, Fivaz, M, Kraus, MS, and Keefe, RSE. "Hierarchical temporal processing deficit model of reality distortion and psychoses (Molecular Psychiatry (2011) 16, (129-144) DOI: 10.1038/mp.2010.63)." Molecular Psychiatry 17, no. 4 (2012): 470--. Full Text
  - Matza, LS, Phillips, GA, Revicki, DA, Ascher-Svanum, H, Malley, KG, Palsgrove, AC, Faries, DE, Stauffer, V, Kinon, BJ, Awad, AG, Keefe, RSE, and Naber, D. "Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation." PATIENT PREFERENCE AND ADHERENCE 6 (2012): 521-532. Full Text Link to Item
  - Matza, LS, Phillips, GA, Revicki, DA, Ascher-Svanum, H, Malley, KG, Palsgrove, AC, Faries, DE, Stauffer, V, Kinon, BJ, Awad, AG, Keefe, RSE, and Naber, D. "Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia." Psychiatry Research 200, no. 2-3 (2012): 835-842. Full Text
  - Matza, LS, Phillips, GA, Revicki, DA, Ascher-Svanum, H, Malley, KG, Palsgrove, AC, Faries, DE, Stauffer, V, Kinon, BJ, Awad, AG, and al, E. "Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia." Psychiatry Research (2012). Full Text
  - Weiser, M, Gershon, AA, Rubinstein, K, Petcu, C, Ladea, M, Sima, D, Podea, D, Keefe, RSE, and Davis, JM. "A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder." Schizophrenia Research 138, no. 1 (2012): 35-38. Full Text
  - Caroff, SN, Davis, VG, Miller, DD, Davis, SM, Rosenheck, RA, McEvoy, JP, Campbell, EC, Saltz, BL, Riggio, S, Chakos, MH, Swartz, MS, Keefe, RSE, Stroup, TS, Lieberman, JA, and CATIE Investigators, . "Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia." J Clin Psychiatry 72, no. 3 (March 2011): 295-303. Full Text Link to Item
  - Buchanan, RW, Keefe, RSE, Lieberman, JA, Barch, DM, Csernansky, JG, Goff, DC, Gold, JM, Green, MF, Jarskog, LF, Javitt, DC, Kimhy, D, Kraus, MS, McEvoy, JP, Mesholam-Gately, RI, Seidman, LJ, Ball, MP, McMahon, RP, Kern, RS, Robinson, J, and Marder, SR. "A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia." Biological Psychiatry 69, no. 5 (2011): 442-449. Full Text
  - Buchanan, RW, Keefe, RSE, Umbricht, D, Green, MF, Laughren, T, and Marder, SR. "The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: What do we know 5 years later?." Schizophrenia Bulletin 37, no. 6 (2011): 1209-1217. Full Text
  - Burdick, KE, Goldberg, TE, Cornblatt, BA, Keefe, RS, Gopin, CB, Derosse, P, Braga, RJ, and Malhotra, AK. "The MATRICS consensus cognitive battery in patients with bipolar i disorder." Neuropsychopharmacology 36, no. 8 (2011): 1587-1592. Full Text
  - Chong, S-A, Campbell, A, Chee, M, Liu, J, Marx, C, Mcgorry, P, Subramaniam, M, Yung, A, and Keefe, RSE. "The Singapore flagship programme in translational and clinical research in psychosis." Early Intervention in Psychiatry 5, no. 4 (2011): 290-300. Full Text
  - Greenberg, G, Rosenheck, RA, Erickson, SK, Desai, RA, Stefanovics, EA, Swartz, M, Keefe, RSE, McEvoy, J, and Stroup, TS. "Criminal justice system involvement among people with schizophrenia." Community Mental Health Journal 47, no. 6 (2011): 727-736. Full Text
  - Harvey, PD, Ogasa, M, Cucchiaro, J, Loebel, A, and Keefe, RSE. "Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone." Schizophrenia Research 127, no. 1-3 (2011): 188-194. Full Text
  - Hurford, IM, Marder, SR, Keefe, RSE, Reise, SP, and Bilder, RM. "A brief cognitive assessment tool for schizophrenia: Construction of a tool for clinicians." Schizophrenia Bulletin 37, no. 3 (2011): 538-545. Full Text
  - Keefe, RSE, Fox, KH, Harvey, PD, Cucchiaro, J, Siu, C, and Loebel, A. "Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial." Schizophrenia Research 125, no. 2-3 (2011): 161-168. Full Text
  - Keefe, RSE, Kraus, MS, and Krishnan, RR. "Failures in learning-dependent predictive perception as the key cognitive vulnerability to psychosis in schizophrenia." Neuropsychopharmacology 36, no. 1 (2011): 367-368. Full Text
  - Keefe, RSE, Vinogradov, S, Medalia, A, Silverstein, SM, Bell, MD, Dickinson, D, Ventura, J, Marder, SR, and Stroup, TS. "Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia." Schizophrenia Bulletin 37, no. 5 (2011): 1057-1065. Full Text
  - Kerfoot, KE, Rosenheck, RA, Petrakis, IL, Swartz, MS, Keefe, RSE, McEvoy, JP, and Stroup, TS. "Substance use and schizophrenia: Adverse correlates in the CATIE study sample." Schizophrenia Research 132, no. 2-3 (2011): 177-182. Full Text
  - Kern, RS, Gold, JM, Dickinson, D, Green, MF, Nuechterlein, KH, Baade, LE, Keefe, RSE, Mesholam-Gately, RI, Seidman, LJ, Lee, C, Sugar, CA, and Marder, SR. "The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study." Schizophrenia Research 126, no. 1-3 (2011): 124-131. Full Text
  - Krishnan, RR, Fivaz, M, Kraus, MS, and Keefe, RSE. "Hierarchical temporal processing deficit model of reality distortion and psychoses." Molecular Psychiatry 16, no. 2 (2011): 129-144. Full Text
  - Krishnan, RR, Kraus, MS, and Keefe, RSE. "Comprehensive model of how reality distortion and symptoms occur in schizophrenia: Could impairment in learning-dependent predictive perception account for the manifestations of schizophrenia?." Psychiatry and Clinical Neurosciences 65, no. 4 (2011): 305-317. Full Text
  - Marder, SR, Daniel, DG, Alphs, L, Awad, AG, and Keefe, RSE. "Methodological issues in negative symptom trials." Schizophrenia Bulletin 37, no. 2 (2011): 250-254. Full Text
  - McClay, JL, Adkins, DE, Berg, K, Bukszár, J, Khachane, AN, Keefe, RSE, Perkins, DO, McEvoy, JP, Stroup, TS, Vann, RE, Beardsley, PM, Lieberman, JA, Sullivan, PF, and Oord, EJCGVD. "Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia." Neuropsychopharmacology 36, no. 3 (2011): 616-626. Full Text
  - Reise, SP, Ventura, J, Keefe, RSE, Baade, LE, Gold, JM, Green, MF, Kern, RS, Mesholam-Gately, R, Nuechterlein, KH, Seidman, LJ, and Bilder, R. "Bifactor and Item Response Theory Analyses of Interviewer Report Scales of Cognitive Impairment in Schizophrenia." Psychological Assessment 23, no. 1 (2011): 245-261. Full Text
  - Sachs, G, Winklbaur, B, Jagsch, R, and Keefe, RSE. "Validation of the German version of the Brief Assessment of Cognition in Schizophrenia (BACS) - Preliminary results." European Psychiatry 26, no. 2 (2011): 74-77. Full Text
  - Segarra, N, Bernardo, M, Gutierrez, F, Justicia, A, Fernadez-Egea, E, Allas, M, Safont, G, Contreras, F, Gascon, J, Soler-Insa, PA, Menchon, JM, Junque, C, and Keefe, RSE. "Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls." European Psychiatry 26, no. 2 (2011): 69-73. Full Text
  - Sim, K, Lee, J, Subramaniam, M, Liu, JJ, Keefe, R, Zhang, XD, Lee, TS, and Chong, SA. "Integrated genetic and genomic approach in the Singapore translational and clinical research in psychosis study: An overview." Early Intervention in Psychiatry 5, no. 2 (2011): 91-99. Full Text
  - Stroup, TS, Appelbaum, PS, Gu, H, Hays, S, Swartz, MS, Keefe, RSE, Kim, SY, Manschreck, TC, Boshes, RA, McEvoy, JP, and Lieberman, JA. "Longitudinal consent-related abilities among research participants with schizophrenia: Results from the CATIE study." Schizophrenia Research 130, no. 1-3 (2011): 47-52. Full Text
  - Vigen, CLP, Mack, WJ, Keefe, RSE, Sano, M, Sultzer, DL, Stroup, TS, Dagerman, KS, Hsiao, JK, Lebowitz, BD, Lyketsos, CG, Tariot, PN, Zheng, L, and Schneider, LS. "Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: Outcomes from CATIE-AD." American Journal of Psychiatry 168, no. 8 (2011): 831-839. Full Text
  - Kane, JM, D'Souza, DC, Patkar, AA, Youakim, JM, Tiller, JM, Yang, R, and Keefe, RSE. "Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study." J Clin Psychiatry 71, no. 11 (November 2010): 1475-1481. Full Text Link to Item
  - LaMonica, HM, Keefe, RSE, Harvey, PD, Gold, JM, and Goldberg, TE. "Differential effects of emotional information on interference task performance across the life span." FRONTIERS IN AGING NEUROSCIENCE 2 (September 30, 2010). Full Text Link to Item
  - Polanczyk, G, Moffitt, TE, Arseneault, L, Cannon, M, Ambler, A, Keefe, RSE, Houts, R, Odgers, CL, and Caspi, A. "Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort." Arch Gen Psychiatry 67, no. 4 (April 2010): 328-338. Full Text Link to Item
  - Reichenberg, A, Caspi, A, Harrington, H, Houts, R, Keefe, RSE, Murray, RM, Poulton, R, and Moffitt, TE. "Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study." Am J Psychiatry 167, no. 2 (February 2010): 160-169. Full Text Link to Item
  - Ascher-Svanum, H, Nyhuis, AW, Stauffer, V, Kinon, BJ, Faries, DE, Phillips, GA, Schuh, K, Awad, AG, Keefe, R, and Naber, D. "Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives." Current Medical Research and Opinion 26, no. 10 (2010): 2403-2410. Full Text
  - Barch, DM, and Keefe, RSE. "Anticipating DSM-V: Opportunities and challenges for cognition and psychosis." Schizophrenia Bulletin 36, no. 1 (2010): 43-47. Full Text
  - Chan, W-Y, Yang, G-L, Chia, M-Y, Woon, P-S, Lee, J, Keefe, R, Sitoh, Y-Y, Nowinski, WL, and Sim, K. "Cortical and subcortical white matter abnormalities in adults with remitted first-episode mania revealed by Tract-Based Spatial Statistics." Bipolar Disorders 12, no. 4 (2010): 383-389. Full Text
  - Chia, MY, Chan, WY, Chua, KY, Lee, H, Lee, J, Lee, R, Lim, C, Tay, E, Woon, PS, Keefe, RSE, and Sim, K. "The Schizophrenia cognition Rating Scale: Validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia." Psychiatry Research 178, no. 1 (2010): 33-38. Full Text
  - Goldberg, TE, Keefe, RSE, Goldman, RS, Robinson, DG, and Harvey, PD. "Circumstances under which practice does not make perfect: A review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies." Neuropsychopharmacology 35, no. 5 (2010): 1053-1062. Full Text
  - Keefe, RSE. "Neurocognition." (January 1, 2010): 97-119. (Chapter) Full Text
  - Konneker, TI, Crowley, JJ, Quackenbush, CR, Keefe, RSE, Perkins, DO, Stroup, TS, Lieberman, JA, Oord, EVD, and Sullivan, PF. "No association of the serotonin transporter polymorphisms 5-HTTLPR and rs25531 with schizophrenia or neurocognition." American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 153, no. 5 (2010): 1115-1117. Full Text
  - Seidman, LJ, Giuliano, AJ, Meyer, EC, Addington, J, Cadenhead, KS, Cannon, TD, McGlashan, TH, Perkins, DO, Tsuang, MT, Walker, EF, Woods, SW, Bearden, CE, Christensen, BK, Hawkins, K, Heaton, R, Keefe, RSE, Heinssen, R, and Cornblatt, BA. "Neuropsychology of the prodrome to psychosis in the NAPLS Consortium: Relationship to family history and conversion to psychosis." Archives of General Psychiatry 67, no. 6 (2010): 578-588. Full Text
  - Ventura, J, Reise, SP, Keefe, RSE, Baade, LE, Gold, JM, Green, MF, Kern, RS, Mesholam-Gately, R, Nuechterlein, KH, Seidman, LJ, and Bilder, RM. "The Cognitive Assessment Interview (CAI): Development and validation of an empirically derived, brief interview-based measure of cognition." Schizophrenia Research 121, no. 1-3 (2010): 24-31. Full Text
  - Marx, CE, Keefe, RSE, Buchanan, RW, Hamer, RM, Kilts, JD, Bradford, DW, Strauss, JL, Naylor, JC, Payne, VM, Lieberman, JA, Savitz, AJ, Leimone, LA, Dunn, L, Porcu, P, Morrow, AL, and Shampine, LJ. "Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia." Neuropsychopharmacology 34, no. 8 (July 2009): 1885-1903. Full Text Link to Item
  - Need, AC, Keefe, RSE, Ge, D, Grossman, I, Dickson, S, McEvoy, JP, and Goldstein, DB. "Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis." Eur J Hum Genet 17, no. 7 (July 2009): 946-957. Full Text Link to Item
  - Need, AC, Ge, D, Weale, ME, Maia, J, Feng, S, Heinzen, EL, Shianna, KV, Yoon, W, Kasperaviciūte, D, Gennarelli, M, Strittmatter, WJ, Bonvicini, C, Rossi, G, Jayathilake, K, Cola, PA, McEvoy, JP, Keefe, RSE, Fisher, EMC, St Jean, PL, Giegling, I, Hartmann, AM, Möller, H-J, Ruppert, A, Fraser, G, Crombie, C, Middleton, LT, St Clair, D, Roses, AD, Muglia, P, Francks, C, Rujescu, D, Meltzer, HY, and Goldstein, DB. "A genome-wide investigation of SNPs and CNVs in schizophrenia." PLoS Genet 5, no. 2 (February 2009): e1000373-. Full Text Link to Item
  - Davidson, M, Galderisi, S, Weiser, M, Werbeloff, N, Fleischhacker, WW, Keefe, RS, Boter, H, Keet, IPM, Prelipceanu, D, Rybakowski, JK, Libiger, J, Hummer, M, Dollfus, S, López-Ibor, JJ, Hranov, LG, Gaebel, W, Peuskens, J, Lindefors, N, Riecher-Rössler, A, and Kahn, RS. "Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: A randomized, open-label clinical trial (EUFEST)." American Journal of Psychiatry 166, no. 6 (2009): 675-682. Full Text
  - Fox, KH, Burdick, KE, Lombardo, I, and Keefe, RSE. "Cognitive impairment in patients with bipolar disorder." Psychiatric Times 26, no. 12 (2009): 66-68.
  - Harvey, PD, Keefe, RSE, Patterson, TL, Heaton, RK, and Bowie, CR. "Abbreviated neuropsychological assessment in schizophrenia: Prediction of different aspects of outcome." Journal of Clinical and Experimental Neuropsychology 31, no. 4 (2009): 462-471. Full Text
  - Keefe, RSE, Seidman, LJ, Christensen, BK, Hamer, RM, Sharma, T, Sitskoorn, MM, Lewine, RRJ, Yurgelun-Todd, DA, Gur, RC, Tohen, M, Tollefson, GD, Sanger, TM, and Lieberman, JA. "Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzapine versus low doses of haloperidol (American Journal of Psychiatry (2004) 161, (985-995))." American Journal of Psychiatry 166, no. 8 (2009): 942--.
  - Keefe, RSE, and Kraus, MS. "Measuring memory-prediction errors and their consequences in youth at risk for schizophrenia." Annals of the Academy of Medicine Singapore 38, no. 5 (2009): 414-419.
  - Kern, RS, Green, MF, Nuechterlein, KH, and Keefe, RSE. "CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al." Schizophrenia research 107, no. 2-3 (2009): 327-329. Full Text
  - Kern, RS, Green, MF, Nuechterlein, KH, and Keefe, RSE. "Commentary on O'Halloran et al." Schizophrenia Research 107, no. 2-3 (2009): 327-329. Full Text
  - Kleinman, L, Lieberman, J, Dube, S, Mohs, R, Zhao, Y, Kinon, B, Carpenter, W, Harvey, PD, Green, MF, Keefe, RSE, Frank, L, Bowman, L, and Revicki, DA. "Development and psychometric performance of the schizophrenia objective functioning instrument: An interviewer administered measure of function." Schizophrenia Research 107, no. 2-3 (2009): 275-285. Full Text
  - Kraus, MS, Keefe, RSE, and Krishnan, RKR. "Memory-prediction errors and their consequences in schizophrenia." Neuropsychology Review 19, no. 3 (2009): 336-352. Full Text
  - Krishnan, RR, Keefe, R, and Kraus, M. "Schizophrenia is a disorder of higher order hierarchical processing." Medical Hypotheses 72, no. 6 (2009): 740-744. Full Text
  - Lim, C, Chong, S-A, and Keefe, RSE. "Psychosocial factors in the neurobiology of schizophrenia: A selective review." Annals of the Academy of Medicine Singapore 38, no. 5 (2009): 402-407.
  - Lipkovich, IA, Deberdt, W, Csernansky, JG, Sabbe, B, Keefe, RSE, and Kollack-Walker, S. "Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: A path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy." BMC Psychiatry 9 (2009). Full Text
  - Penn, DL, Keefe, RSE, Davis, SM, Meyer, PS, Perkins, DO, Losardo, D, and Lieberman, JA. "The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial." Schizophrenia Research 115, no. 1 (2009): 17-23. Full Text
  - Pinheiro, AP, Keefe, RSE, Skelly, T, Olarte, M, Leviel, K, Lange, LA, Lange, EM, Stroup, TS, Lieberman, J, and Sullivan, PF. "Erratum: Rates of depressive and anxiety disorders in a residential mother-infant unit for unsettled infants (Australian and New Zealand Journal of Psychiatry (2007) 41 (836-842))." Australian and New Zealand Journal of Psychiatry 43, no. 11 (2009): 1087--. Full Text
  - Pinheiro, AP, Keefe, RSE, Skelly, T, Olarte, M, Leviel, K, Lange, LA, Lange, EM, StroupT, S, Lieberman, J, and Sullivan, PF. "Erratum: AKT1 and neurocognition in schizophrenia (Australian and New Zealand Journal of Psychiatry (2007) 41 (169-177))." Australian and New Zealand Journal of Psychiatry 43, no. 10 (2009): 983--. Full Text
  - Sim, K, Yang, GL, Loh, D, Poon, LY, Sitoh, YY, Verma, S, Keefe, R, Collinson, S, Chong, SA, Heckers, S, Nowinski, W, and Pantelis, C. "White matter abnormalities and neurocognitive deficits associated with the passivity phenomenon in schizophrenia: A diffusion tensor imaging study." Psychiatry Research - Neuroimaging 172, no. 2 (2009): 121-127. Full Text
  - Stroup, TS, Lieberman, JA, McEvoy, JP, Davis, SM, Swartz, MS, Keefe, RSE, Miller, AL, Rosenheck, RA, Hsiao, JK, and CATIE Investigators, . "Results of phase 3 of the CATIE schizophrenia trial." Schizophr Res 107, no. 1 (January 2009): 1-12. Full Text Link to Item
  - Miller, DD, Caroff, SN, Davis, SM, Rosenheck, RA, McEvoy, JP, Saltz, BL, Riggio, S, Chakos, MH, Swartz, MS, Keefe, RSE, Stroup, TS, Lieberman, JA, and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators, . "Extrapyramidal side-effects of antipsychotics in a randomised trial." Br J Psychiatry 193, no. 4 (October 2008): 279-288. Full Text Link to Item
  - Keefe, RSE, Malhotra, AK, Meltzer, HY, Kane, JM, Buchanan, RW, Murthy, A, Sovel, M, Li, C, and Goldman, R. "Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial." Neuropsychopharmacology 33, no. 6 (May 2008): 1217-1228. Full Text Link to Item
  - Lieberman, JA, Drake, RE, Sederer, LI, Belger, A, Keefe, R, Perkins, D, and Stroup, S. "Science and recovery in schizophrenia." Psychiatr Serv 59, no. 5 (May 2008): 487-496. (Review) Full Text Link to Item
  - Swartz, MS, Stroup, TS, McEvoy, JP, Davis, SM, Rosenheck, RA, Keefe, RSE, Hsiao, JK, and Lieberman, JA. "What CATIE found: results from the schizophrenia trial." Psychiatr Serv 59, no. 5 (May 2008): 500-506. Full Text Link to Item
  - Crowley, JJ, Keefe, RSE, Perkins, DO, Stroup, TS, Lieberman, JA, and Sullivan, PF. "The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition." American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 147, no. 7 (2008): 1298-1300. Full Text
  - Green, MF, Nuechterlein, KH, Kern, RS, Baade, LE, Fenton, WS, Gold, JM, Keefe, RSE, Mesholam-Gately, R, Seidman, LJ, Stover, E, and Marder, SR. "Functional co-primary measures for clinical trials in schizophrenia: Results from the MATRICS Psychometric and Standardization Study." American Journal of Psychiatry 165, no. 2 (2008): 221-228. Full Text
  - Hawkins, KA, Keefe, RSE, Christensen, BK, Addington, J, Woods, SW, Callahan, J, Zipursky, RB, Perkins, DO, Tohen, M, Breier, A, and McGlashan, TH. "Neuropsychological course in the prodrome and first episode of psychosis: Findings from the PRIME North America Double Blind Treatment Study." Schizophrenia Research 105, no. 1-3 (2008): 1-9. Full Text
  - Hill, SK, Sweeney, JA, Hamer, RM, Keefe, RSE, Perkins, DO, Gu, H, Mcevoy, JP, and Lieberman, JA. "Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia." Journal of the International Neuropsychological Society 14, no. 2 (2008): 209-221. Full Text
  - Keefe, RSE, Harvey, PD, Goldberg, TE, Gold, JM, Walker, TM, Kennel, C, and Hawkins, K. "Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)." Schizophrenia Research 102, no. 1-3 (2008): 108-115. Full Text
  - Keefe, RSE, and Harvey, PD. "Implementation considerations for multisite clinical trials with cognitive neuroscience tasks." Schizophrenia Bulletin 34, no. 4 (2008): 656-663. Full Text
  - Keefe, RSE. "Should cognitive impairment be included in the diagnostic criteria for schizophrenia?." World Psychiatry 7, no. 1 (2008): 22-28.
  - Kern, RS, Nuechterlein, KH, Green, MF, Baade, LE, Fenton, WS, Gold, JM, Keefe, RSE, Mesholam-Gately, R, Mintz, J, Seidman, LJ, Stover, E, and Marder, SR. "The MATRICS Consensus Cognitive Battery, part 2: Co-norming and standardization." American Journal of Psychiatry 165, no. 2 (2008): 214-220. Full Text
  - Mohamed, S, Rosenheck, R, Swartz, M, Stroup, S, Lieberman, JA, and Keefe, RSE. "Relationship of cognition and psychopathology to functional impairment in schizophrenia." American Journal of Psychiatry 165, no. 8 (2008): 978-987. Full Text
  - Nuechterlein, KH, Green, MF, Kern, RS, Baade, LE, Barch, DM, Cohen, JD, Essock, S, Fenton, WS, III, FJF, Gold, JM, Goldberg, T, Heaton, RK, Keefe, RSE, Kraemer, H, Mesholam-Gately, R, Seidman, LJ, Stover, E, Weinberger, DR, Young, AS, Zalcman, S, and Marder, SR. "The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity." American Journal of Psychiatry 165, no. 2 (2008): 203-213. Full Text
  - Resnick, SG, Rosenheck, RA, Canive, JM, Souza, CD, Stroup, TS, McEvoy, J, Davis, S, Keefe, RSE, Swartz, M, and Lieberman, J. "Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia." Journal of Behavioral Health Services and Research 35, no. 2 (2008): 215-225. Full Text
  - Keefe, RSE, Sweeney, JA, Gu, H, Hamer, RM, Perkins, DO, McEvoy, JP, and Lieberman, JA. "Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison." Am J Psychiatry 164, no. 7 (July 2007): 1061-1071. Full Text Link to Item
  - Keefe, RSE, Bilder, RM, Davis, SM, Harvey, PD, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Capuano, G, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, Davis, CE, Hsiao, JK, Lieberman, JA, CATIE Investigators, , and Neurocognitive Working Group, . "Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial." Arch Gen Psychiatry 64, no. 6 (June 2007): 633-647. Full Text Link to Item
  - Stroup, TS, Lieberman, JA, McEvoy, JP, Swartz, MS, Davis, SM, Capuano, GA, Rosenheck, RA, Keefe, RSE, Miller, AL, Belz, I, Hsiao, JK, and CATIE Investigators, . "Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study." Am J Psychiatry 164, no. 3 (March 2007): 415-427. Full Text Link to Item
  - Swartz, MS, Perkins, DO, Stroup, TS, Davis, SM, Capuano, G, Rosenheck, RA, Reimherr, F, McGee, MF, Keefe, RSE, McEvoy, JP, Hsiao, JK, Lieberman, JA, and CATIE Investigators, . "Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study." Am J Psychiatry 164, no. 3 (March 2007): 428-436. Full Text Link to Item
  - Bralet, M-C, Falissard, B, Neveu, X, Lucas-Ross, M, Eskenazi, A-M, and Keefe, RSE. "Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients." European Psychiatry 22, no. 6 (2007): 365-370. Full Text
  - Goff, DC, Keefe, R, Citrome, L, Davy, K, Krystal, JH, Large, C, Thompson, TR, Volavka, J, and Webster, EL. "Lamotrigine as add-on therapy in schizophrenia: Results of 2 placebo-controlled trials." Journal of Clinical Psychopharmacology 27, no. 6 (2007): 582-589. Full Text
  - Kaneda, Y, Sumiyoshi, T, Keefe, R, Ishimoto, Y, Numata, S, and Ohmori, T. "Brief Assessment of Cognition in Schizophrenia: Validation of the Japanese version." Psychiatry and Clinical Neurosciences 61, no. 6 (2007): 602-609. Full Text
  - Keefe, RSE, Sweeney, JA, Gu, H, Hamer, RM, Perkins, DO, McEvoy, JP, and Lieberman, JA. "Dr. Keefe and colleagues reply." American Journal of Psychiatry 164, no. 12 (2007): 1911-1912. Full Text
  - Keefe, RSE, and Fenton, WS. "How should DSM-V criteria for schizophrenia include cognitive impairment?." Schizophrenia Bulletin 33, no. 4 (2007): 912-920. Full Text
  - Keefe, RSE. "Cognitive deficits in patients with schizophrenia: Effects and treatment." Journal of Clinical Psychiatry 68, no. SUPPL. 14 (2007): 8-13.
  - Kraus, MS, and Keefe, RSE. "Cognition as an outcome measure in schizophrenia." British Journal of Psychiatry 191, no. SUPPL. 50 (2007): s46-s51. Full Text
  - Pandina, GJ, Bilder, R, Harvey, PD, Keefe, RSE, Aman, MG, and Gharabawi, G. "Risperidone and Cognitive Function in Children With Disruptive Behavior Disorders." Biological Psychiatry 62, no. 3 (2007): 226-234. Full Text
  - Pinheiro, AP, Keefe, RSE, Skelly, T, Olarte, M, Leviel, K, Lange, LA, Lange, EM, Stroup, TS, Lieberman, J, and Sullivan, PF. "AKT1 and neurocognition in schizophrenia." Australian and New Zealand Journal of Psychiatry 41, no. 2 (2007): 169-177. Full Text
  - Rosenheck, R, Stroup, TS, Swartz, M, McEvoy, J, Davis, SM, Keefe, RSE, Hsiao, JK, and Lieberman, J. "Dr. Rosenheck and colleagues reply [2]." American Journal of Psychiatry 164, no. 4 (2007): 678-680.
  - Rosenheck, R, Swartz, M, McEvoy, J, Stroup, TS, Davis, S, Keefe, RSE, Hsiao, J, and Lieberman, J. "Second-generation antipsychotics: Reviewing the cost-effectiveness component of the CATIE trial." Expert Review of Pharmacoeconomics and Outcomes Research 7, no. 2 (2007): 103-111. Full Text
  - Sullivan, PF, Keefe, RSE, Lange, LA, Lange, EM, Stroup, TS, Lieberman, J, and Maness, PF. "NCAM1 and Neurocognition in Schizophrenia." Biological Psychiatry 61, no. 7 (2007): 902-910. Full Text
  - Keefe, RSE, Perkins, DO, Gu, H, Zipursky, RB, Christensen, BK, and Lieberman, JA. "A longitudinal study of neurocognitive function in individuals at-risk for psychosis." Schizophr Res 88, no. 1-3 (December 2006): 26-35. Full Text Link to Item
  - McEvoy, JP, Johnson, J, Perkins, D, Lieberman, JA, Hamer, RM, Keefe, RSE, Tohen, M, Glick, ID, and Sharma, T. "Insight in first-episode psychosis." Psychol Med 36, no. 10 (October 2006): 1385-1393. Full Text Link to Item
  - Keefe, RSE, Bilder, RM, Harvey, PD, Davis, SM, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Miller, DD, Canive, JM, Adler, LW, Manschreck, TC, Swartz, M, Rosenheck, R, Perkins, DO, Walker, TM, Stroup, TS, McEvoy, JP, and Lieberman, JA. "Baseline neurocognitive deficits in the CATIE schizophrenia trial." Neuropsychopharmacology 31, no. 9 (September 2006): 2033-2046. Full Text Link to Item
  - Chwastiak, LA, Rosenheck, RA, McEvoy, JP, Keefe, RS, Swartz, MS, and Lieberman, JA. "Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia." Psychiatr Serv 57, no. 8 (August 2006): 1102-1109. Full Text Link to Item
  - McEvoy, JP, Lieberman, JA, Stroup, TS, Davis, SM, Meltzer, HY, Rosenheck, RA, Swartz, MS, Perkins, DO, Keefe, RSE, Davis, CE, Severe, J, Hsiao, JK, and CATIE Investigators, . "Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment." Am J Psychiatry 163, no. 4 (April 2006): 600-610. Full Text Link to Item
  - Stroup, TS, Lieberman, JA, McEvoy, JP, Swartz, MS, Davis, SM, Rosenheck, RA, Perkins, DO, Keefe, RSE, Davis, CE, Severe, J, Hsiao, JK, and CATIE Investigators, . "Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic." Am J Psychiatry 163, no. 4 (April 2006): 611-622. Full Text Link to Item
  - Keefe, RSE, Seidman, LJ, Christensen, BK, Hamer, RM, Sharma, T, Sitskoorn, MM, Rock, SL, Woolson, S, Tohen, M, Tollefson, GD, Sanger, TM, Lieberman, JA, and HGDH Research Group, . "Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis." Biol Psychiatry 59, no. 2 (January 15, 2006): 97-105. Full Text Link to Item
  - Chakos, MH, Glick, ID, Miller, AL, Hamner, MB, Miller, DD, Patel, JK, Tapp, A, Keefe, RSE, and Rosenheck, RA. "Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial." Psychiatric Services 57, no. 8 (2006): 1094-1101. Full Text
  - Keefe, RSE, Poe, M, Walker, TM, Kang, JW, and Harvey, PD. "The schizophrenia cognition rating scale: An interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity." American Journal of Psychiatry 163, no. 3 (2006): 426-432. Full Text
  - Keefe, RSE, Poe, M, Walker, TM, and Harvey, PD. "The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome." Journal of Clinical and Experimental Neuropsychology 28, no. 2 (2006): 260-269. Full Text
  - Keefe, RSE, Young, CA, Rock, SL, Purdon, SE, Gold, JM, and Breier, A. "One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia." Schizophrenia Research 81, no. 1 (2006): 1-5. Full Text
  - Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, Keefe, RSE, Davis, SM, Davis, CE, Hsiao, J, Severe, J, and Lebowitz, BD. "Dr. Lieberman and Colleagues reply [17]." American Journal of Psychiatry 163, no. 3 (2006): 555-556.
  - Perkins, DO, Johnson, JL, Hamer, RM, Zipursky, RB, Keefe, RS, Centorrhino, F, Green, AI, Glick, IB, Kahn, RS, Sharma, T, Tohen, M, McEvoy, JP, Weiden, PJ, Lieberman, JA, Lieberman, JA, Perkins, D, Hamer, R, Nemeroff, CB, Cohen, B, Centhorrino, F, Tollefson, G, Sanger, T, Tohen, M, McEvoy, JP, Kuldau, J, Green, AI, Rothschild, AJ, Patel, JK, Gur, RE, Zipursky, RB, Daskalakis, ZJ, Strakowski, SM, Glick, IB, Quardo, JD, Kahn, RS, Sharma, T, and Murray, R. "Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode." Schizophrenia Research 83, no. 1 (2006): 53-63. Full Text
  - Rosenheck, R, Leslie, D, Keefe, R, McEvoy, J, Swartz, M, Perkins, D, Stroup, S, Hsiao, JK, and Lieberman, J. "Barriers to employment for people with schizophrenia." American Journal of Psychiatry 163, no. 3 (2006): 411-417. Full Text
  - Rosenheck, RA, Leslie, DL, Sindelar, J, Miller, EA, Lin, H, Stroup, TS, McEvoy, J, Davis, SM, Keefe, RSE, Swartz, M, Perkins, DO, Hsiao, JK, and Lieberman, J. "Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia." American Journal of Psychiatry 163, no. 12 (2006): 2080-2089. Full Text
  - Woodward, TS, Menon, M, Hu, X, and Keefe, RSE. "Optimization of a multinomial model for investigating hallucinations and delusions with source monitoring." Schizophrenia Research 85, no. 1-3 (2006): 106-112. Full Text
  - Miller, DD, McEvoy, JP, Davis, SM, Caroff, SN, Saltz, BL, Chakos, MH, Swartz, MS, Keefe, RSE, Rosenheck, RA, Stroup, TS, and Lieberman, JA. "Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial." Schizophr Res 80, no. 1 (December 1, 2005): 33-43. Full Text Link to Item
  - Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, Keefe, RSE, Davis, SM, Davis, CE, Lebowitz, BD, Severe, J, Hsiao, JK, and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators, . "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia." N Engl J Med 353, no. 12 (September 22, 2005): 1209-1223. Full Text Link to Item
  - Buchanan, RW, Davis, M, Goff, D, Green, MF, Keefe, RSE, Leon, AC, Nuechterlein, KH, Laughren, T, Levin, R, Stover, E, Fenton, W, and Marder, SR. "A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia." Schizophrenia Bulletin 31, no. 1 (2005): 5-19. Full Text
  - Fortuny, LAI, Garolera, M, Romo, DH, Feldman, E, Barillas, HF, Keefe, R, Lemaêtre, MJ, Martín, AO, Mirsky, A, Monguió, I, Morote, G, Parchment, S, Parchment, LJ, Pena, ED, Politis, DG, Sedó, MA, Taussik, I, Valdivia, F, Valdivia, LED, and Maestre, KV. "Research with Spanish-speaking populations in the United States: Lost in the translation - A commentary and a plea." Journal of Clinical and Experimental Neuropsychology 27, no. 5 (2005): 555-564. Full Text
  - Keefe, RSE, Eesley, CE, and Poe, MP. "Defining a cognitive function decrement in schizophrenia." Biological Psychiatry 57, no. 6 (2005): 688-691. Full Text
  - Lieberman, JA, Tollefson, GD, Charles, C, Zipursky, R, Sharma, T, Kahn, RS, Keefe, RSE, Green, AI, Gur, RE, McEvoy, J, Perkins, D, Hamer, RM, Gu, H, and Tohen, M. "Antipsychotic drug effects on brain morphology in first-episode psychosis." Archives of General Psychiatry 62, no. 4 (2005): 361-370. Full Text
  - Meyer, JM, Nasrallah, HA, McEvoy, JP, Goff, DC, Davis, SM, Chakos, M, Patel, JK, Keefe, RSE, Stroup, TS, and Lieberman, JA. "The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome." Schizophrenia Research 80, no. 1 (2005): 9-18. Full Text
  - Narendran, R, Frankle, WG, Keefe, R, Gil, R, Martinez, D, Slifstein, M, Kegeles, LS, Talbot, PS, Huang, Y, Hwang, D-R, Khenissi, L, Cooper, TB, Laruelle, M, and Abi-Dargham, A. "Altered prefrontal dopaminergic function in chronic recreational ketamine users." American Journal of Psychiatry 162, no. 12 (2005): 2352-2359. Full Text
  - Rosenheck, R, Stroup, S, Keefe, RSE, McEvoy, J, Swartz, M, Perkins, D, Hsiao, J, Shumway, M, and Lieberman, J. "Measuring outcome priorities and preferences in people with schizophrenia." British Journal of Psychiatry 187, no. DEC. (2005): 529-534. Full Text
  - Strakowski, SM, Johnson, JL, DelBello, MP, Hamer, RM, Green, AI, Tohen, M, Lieberman, JA, Glick, I, Patel, JK, Lieberman, J, Perkins, D, McEvoy, JP, Charles, C, Keefe, R, Zipursky, RB, Daskalakis, ZJ, Green, AI, Nemeroff, CB, Murray, R, Sharma, T, Gur, RE, Cohen, B, Centorrino, F, Kahn, RS, Goodman, W, Kuldau, J, Rothschild, AJ, Quardo, JD, Tollefson, G, and Sanger, T. "Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode." Schizophrenia Research 78, no. 2-3 (2005): 161-169. Full Text
  - Stroup, S, Appelbaum, P, Swartz, M, Patel, M, Davis, S, Jeste, D, Kim, S, Keefe, R, Manschreck, T, McEvoy, J, and Lieberman, J. "Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial." Schizophrenia Research 80, no. 1 (2005): 1-8. Full Text
  - Keefe, RSE, Seidman, LJ, Christensen, BK, Hamer, RM, Sharma, T, Sitskoorn, MM, Lewine, RRJ, Yurgelun-Todd, DA, Gur, RC, Tohen, M, Tollefson, GD, Sanger, TM, and Lieberman, JA. "Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol." Am J Psychiatry 161, no. 6 (June 2004): 985-995. Full Text Link to Item
  - Green, MF, Nuechterlein, KH, Gold, JM, Barch, DM, Cohen, J, Essock, S, Fenton, WS, Frese, F, Goldberg, TE, Heaton, RK, Keefe, RSE, Kern, RS, Kraemer, H, Stover, E, Weinberger, DR, Zalcman, S, and Marder, SR. "Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria." Biological Psychiatry 56, no. 5 (2004): 301-307. Full Text
  - Harvey, PD, Green, MF, Keefe, RSE, and Velligan, DI. "Cognitive functioning in schizophrenia: A consensus statement on its role in the definition and evaluation of effective treatments for the illness." Journal of Clinical Psychiatry 65, no. 3 (2004): 361-372. Full Text
  - Hawkins, KA, Addington, J, Keefe, RSE, Christensen, B, Perkins, DO, Zipurksy, R, Woods, SW, Miller, TJ, Marquez, E, Breier, A, and McGlashan, TH. "Neuropsychological status of subjects at high risk for a first episode of psychosis." Schizophrenia Research 67, no. 2-3 (2004): 115-122. Full Text
  - Keefe, RSE, Goldberg, TE, Harvey, PD, Gold, JM, Poe, MP, and Coughenour, L. "The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery." Schizophrenia Research 68, no. 2-3 (2004): 283-297. Full Text
  - Keefe, RSE, Poe, MP, McEvoy, JP, and Vaughan, A. "Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications." Psychopharmacology (Berl) 169, no. 3-4 (September 2003): 383-389. Full Text Link to Item
  - Keefe, RSE, Mohs, RC, Bilder, RM, Harvey, PD, Green, MF, Meltzer, HY, Gold, JM, and Sano, M. "Neurocognitive assessment in the clinical antipsychotic trials of intervention effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale." Schizophrenia Bulletin 29, no. 1 (2003): 45-55.
  - Keefe, RSE, Arnold, MC, Bayen, UJ, McEvoy, JP, and Wilson, WH. "Source-monitoring deficits for self-generated stimuli in schizophrenia: multinomial modeling of data from three sources." Schizophr Res 57, no. 1 (September 1, 2002): 51-67. Link to Item
  - Conway, CR, Bollini, AM, Graham, BG, Keefe, RSE, Schiffman, SS, and McEvoy, JP. "Sensory acuity and reasoning in delusional disorder." Compr Psychiatry 43, no. 3 (May 2002): 175-178. Link to Item
  - Keefe, RSE. "Evaluation of cognitive dysfunctions in schizophrenia." Encephale 28, no. 5 II (2002): 11-13.
  - Harvey, PD, and Keefe, RSE. "Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment." American Journal of Psychiatry 158, no. 2 (2001): 176-184. Full Text
  - Bollini, AM, Arnold, MC, and Keefe, RSE. "Test-retest reliability of the Dot Test of Visuospatial Working Memory in patients with schizophrenia and controls." Schizophrenia Research 45, no. 1-2 (2000): 169-173. Full Text
  - Roitman, SEL, Mitropoulou, V, Keefe, RSE, Silverman, JM, Serby, M, Harvey, PD, Reynolds, DA, Mohs, RC, and Siever, LJ. "Visuospatial working memory in schizotypal personality disorder patients." Schizophrenia Research 41, no. 3 (2000): 447-455. Full Text
  - Keefe, RS, Silva, SG, Perkins, DO, and Lieberman, JA. "The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis." Schizophr Bull 25, no. 2 (1999): 201-222. Link to Item
  - Keefe, RSE, Arnold, MC, Bayen, UJ, and Harvey, PD. "Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis." Psychological Medicine 29, no. 4 (1999): 903-914. Full Text
  - Keefe, RSE, Bollini, AM, and Silva, SG. "Do novel antipsychotics improve cognition? A report of a meta-analysis." Psychiatric Annals 29, no. 11 (1999): 623-629.
  - Davis, KL, Buchsbaum, MS, Shihabuddin, L, Spiegel-Cohen, J, Metzger, M, Frecska, E, Keefe, RS, and Powchik, P. "Ventricular enlargement in poor-outcome schizophrenia." Biological Psychiatry 43, no. 11 (1998): 783-793. Full Text
  - Harvey, PD, and Keefe, RSE. "Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment." CNS Spectrums 2, no. 8 (December 1, 1997): 41-55. (Review)
  - Harvey, PD, and Keefe, RSE. "Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment." CNS Spectrums 2, no. 8 (1997): 41-55.
  - Keefe, RSE, Lees-Roitman, SE, and Dupre, RL. "Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay." Schizophrenia Research 26, no. 1 (1997): 9-14. Full Text
  - Keefe, RSE, Silverman, JM, Mohs, RC, Siever, LJ, Harvey, PD, Friedman, L, Roitman, SEL, Dupre, RL, Smith, CJ, Schmeidler, J, and Davis, KL. "Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia." Archives of General Psychiatry 54, no. 2 (1997): 169-176.
  - Roitman, SEL, Cornblatt, BA, Bergman, A, Obuchowski, M, Mitropoulou, V, Keefe, RSE, Silverman, JM, and Siever, LJ. "Attentional functioning in schizotypal personality disorder." American Journal of Psychiatry 154, no. 5 (1997): 655-660.
  - Roitman, SEL, Keefe, RSE, Harvey, PD, Siever, LJ, and Mohs, RC. "Attentional and eye tracking deficits correlate with negative symptoms in schizophrenia." Schizophrenia Research 26, no. 2-3 (1997): 139-146. Full Text
  - Vocisano, C, Klein, DN, and Keefe, RSE. "Lifetime comorbidity, lifetime history of psychosis and suicide attempts, and current symptoms of patients with deteriorated affective disorder." Psychiatry Research 73, no. 1-2 (1997): 33-45. Full Text
  - Epstein, JI, Keefe, RSE, Roitman, SL, Harvey, PD, and Mohs, RC. "Impact of neuroleptic medications on continuous performance test measures in schizophrenia." Biological Psychiatry 39, no. 10 (1996): 902-905. Full Text
  - Harvey, PD, Davidson, M, White, L, Keefe, RSE, Hirschowitz, J, Mohs, RC, and Davis, KL. "Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: Effects of typical neuroleptics on the brief psychiatric rating scale." Biological Psychiatry 40, no. 8 (1996): 755-760. Full Text
  - Harvey, PD, Keefe, RSE, Mitroupolou, V, DuPre, R, Roitman, SL, Mohs, RC, and Siever, LJ. "Information-processing markers of vulnerability to schizophrenia: Performance of patients with schizotypal and nonschizotypal personality disorders." Psychiatry Research 60, no. 1 (1996): 49-56. Full Text
  - Jr, BVS, Trestman, RL, O'Flaithbheartaigh, S, Mitropoulou, V, Amin, F, Kirrane, R, Silverman, J, Schmeidler, J, Keefe, RSE, and Siever, LJ. "D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder." Schizophrenia Research 20, no. 1-2 (1996): 29-32. Full Text
  - Keefe, RSE, Frescka, E, Apter, SH, Davidson, M, Macaluso, JM, Hirschowitz, J, and Davis, KL. "Clinical characteristics of Kraepelinian schizophrenia: Replication and extension of previous findings." American Journal of Psychiatry 153, no. 6 (1996): 806-811.
  - Vocisano, C, Klein, DN, Keefe, RSE, Dienst, ER, and Kincaid, MM. "Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder." American Journal of Psychiatry 153, no. 2 (1996): 248-255.
  - Trestman, RL, Keefe, RSE, Mitropoulou, V, Harvey, PD, deVegvar, ML, LeesRoitman, S, Davidson, M, Aronson, A, Silverman, J, and Siever, LJ. "Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder." PSYCHIATRY RESEARCH 59, no. 1-2 (November 29, 1995): 127-136. Full Text Link to Item
  - Davidson, M, Harvey, PD, Powchik, P, Parrella, M, White, L, Knobler, HY, Losonczy, MF, Keefe, RSE, Katz, S, and Frecska, E. "Severity of symptoms in chronically institutionalized geriatric schizophrenic patients." American Journal of Psychiatry 152, no. 2 (1995): 197-207.
  - Davidson, M, and Keefe, RSE. "Cognitive impairment as a target for pharmacological treatment in schizophrenia." Schizophrenia Research 17, no. 1 (1995): 123-129. Full Text
  - Keefe, RSE, Roitman, SEL, Harvey, PD, Blum, CS, DuPre, RL, Prieto, DM, Davidson, M, and Davis, KL. "A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia." Schizophrenia Research 17, no. 1 (1995): 25-33. Full Text
  - Keefe, RSE. "The contribution of neuropsychology to psychiatry." American Journal of Psychiatry 152, no. 1 (1995): 6-15.
  - Yehuda, R, Keefe, RSE, Harvey, PD, Levengood, RA, Gerber, DK, Geni, J, and Siever, LJ. "Learning and memory in combat veterans with posttraumatic stress disorder." American Journal of Psychiatry 152, no. 1 (1995): 137-139.
  - Kahn, R, Harvey, PD, Davidson, M, Keefe, RSE, Apter, S, Neale, JM, Mohs, RC, and Davis, KL. "Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function." Schizophrenia Research 11, no. 3 (1994): 217-224. Full Text
  - Keefe, RSE, Silverman, JM, Roitman, SEL, Harvey, PD, Duncan, MA, Alroy, D, Siever, LJ, Davis, KL, and Mohs, RC. "Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests." Psychiatry Research 53, no. 1 (1994): 1-12. Full Text
  - Siever, LJ, Friedman, L, Moskowitz, J, Mitropoulou, V, Keefe, R, Roitman, SL, Merhige, D, Trestman, R, Silverman, J, and Mohs, R. "Eye movement impairment and schizotypal psychopathology." American Journal of Psychiatry 151, no. 8 (1994): 1209-1215.
  - Frecska, E, Losonczy, MF, Keefe, RSE, Silverman, JM, Davidson, M, and Davis, KL. "The characteristics of poor outcome, 'Kraepelinian' schizophrenia." European Neuropsychopharmacology 3, no. 3 (1993): 400--.
  - Siever, LJ, Kalus, OF, and Keefe, RSE. "The boundaries of schizophrenia." Psychiatric Clinics of North America 16, no. 2 (1993): 217-244.
  - Davidson, M, Kahn, RS, Stern, RG, Harvey, PD, Keefe, R, Knott, P, Apter, S, Webster, L, and Davis, KL. "Measurements of plasma homovanillic acid in schizophrenic patients." Clinical Neuropharmacology 15 Suppl 1 Pt A (1992): 521A-522A.
  - Harvey, PD, Lenzenweger, MF, Keefe, RSE, Pogge, DL, Serper, MR, and Mohs, RC. "Empirical assessment of the factorial structure of clinical symptoms in schizophrenic patients: Formal thought disorder." Psychiatry Research 44, no. 2 (1992): 141-151. Full Text
  - Keefe, RSE, Harvey, PD, Lenzenweger, MF, Davidson, M, Apter, SH, Schmeidler, J, Mohs, RC, and Davis, KL. "Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: Negative symptoms." Psychiatry Research 44, no. 2 (1992): 153-165. Full Text
  - Harvey, PD, Putnam, KM, Davidson, M, Kahn, RS, Powchik, P, McQueeney, R, Keefe, RSE, and Davis, KL. "Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients." Psychiatry Research 38, no. 3 (1991): 285-292. Full Text
  - Keefe, RS, Silverman, JM, Siever, LJ, and Cornblatt, BA. "Refining phenotype characterization in genetic linkage studies of schizophrenia." Social biology 38, no. 3-4 (1991): 197-218.
  - Keefe, RSE, Lobelc, DS, Mohs, RC, Silverman, JM, Harvey, PD, Davidson, M, Losonczy, MF, and Davis, KL. "Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms." Schizophrenia Research 4, no. 2 (1991): 71-79.
  - Thaker, G, Moran, M, Cassady, S, Adami, H, Tamminga, C, Siever, LJ, Keefe, R, Bernstein, DP, Coccaro, EF, Klar, HM, Zemishlany, Z, Peterson, A, Davidson, M, Mahon, T, Horvath, T, and Mohs, R. "Normal smooth pursuit eye movements in volunteer subjects meeting schizotypal personality disorder criteria [16]." American Journal of Psychiatry 148, no. 8 (1991): 1096-1097.
  - Harvey, PD, Keefe, RSE, Moskowitz, J, Putnam, KM, Mohs, RC, and Davis, KL. "Attentional markers of vulnerability to schizophrenia: Performance of medicated and unmedicated patients and normals." Psychiatry Research 33, no. 2 (1990): 179-188. Full Text
  - Siever, LJ, Keefe, R, Bernstein, DP, Coccaro, EF, Klar, HM, Zemishlany, Z, Peterson, AE, Davidson, M, Mahon, T, Horvath, T, and Mohs, R. "Eye tracking impairment in clinically identified patients with schizotypal personality disorder." American Journal of Psychiatry 147, no. 6 (1990): 740-745.
  - Siever, LJ, Silverman, JM, Horvath, TB, Klar, H, Coccaro, E, Keefe, RSE, Pinkham, L, Rinaldi, P, Mohs, RC, and Davis, KL. "Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients." Archives of General Psychiatry 47, no. 7 (1990): 634-640.
  - Keefe, RSE, Mohs, RC, Losonczy, MF, Davidson, MD, Silverman, JM, Horvath, TB, and Davis, KL. "Premorbid sociosexual functioning and long-term outcome in schizophrenia." American Journal of Psychiatry 146, no. 2 (1989): 206-211.
  - Keefe, RSE, Siever, LJ, Mohs, RC, Peterson, AE, Mahon, TR, Bergman, RL, and Davis, KL. "Eye tracking, schizophrenic symptoms, and schizotypal personality disorder." European Archives of Psychiatry and Neurological Sciences 239, no. 1 (1989): 39-42. Full Text
  - Silverman, JM, Keefe, RS, Mohs, RC, and Davis, KL. "A study of the reliability of the family history method in genetic studies of Alzheimer disease." Alzheimer disease and associated disorders 3, no. 4 (1989): 218-223.
  - Keefe, RSE, Mohs, RC, Davidson, M, Losonczy, MF, Silverman, JM, Lesser, JC, Horvath, TB, and Davis, KL. "Kraepelinian schizophrenia: A subgroup of schizophrenia?." Psychopharmacology Bulletin 24, no. 1 (1988): 56-61.
  - Davidson, M, Keefe, RSE, Mohs, RC, Siever, LJ, Losonczy, MF, Horvath, TB, and Davis, KL. "L-Dopa challenge and relapse in schizophrenia." American Journal of Psychiatry 144, no. 7 (1987): 934-938.
  - Keefe, RSE, Mohs, RC, Losonczy, MF, Davidson, M, Silverman, JM, Kendler, KS, Horvath, TB, Nora, R, and Davis, KL. "Characteristics of very poor outcome schizophrenia." American Journal of Psychiatry 144, no. 7 (1987): 889-895.
  - Silverman, JM, Mohs, RC, Davidson, M, Losonczy, MF, Keefe, RSE, Breitner, JCS, Sorokin, JE, and Davis, KL. "Familial schizophrenia and treatment response." American Journal of Psychiatry 144, no. 10 (1987): 1271-1276.
Teaching and Mentoring
Recent Courses

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, and Certifications

In the News

Global Scholarship

Expertise

Research

Selected Grants

Selected Publications

Book Sections

Conference Papers

Journal Articles

Recent Courses